Status:
UNKNOWN
Protocol for Assistance to Patients With Long Covid-19 Undergoing Treatment With HD-tDCS
Lead Sponsor:
Federal University of Paraíba
Conditions:
Coronavirus
COVID-19 Respiratory Infection
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
COVID-19 is an infectious disease which presents a heterogenous clinical presentation. Recent investigations suggest that people who were infected by COVID-19 often develop physical disabilities (i.e....
Detailed Description
We propose a sham-controlled randomized clinical trial with patients in COVID-19 chronic. They will be evaluated according to following eligibility criteria : Patients who had a medical diagnosis of ...
Eligibility Criteria
Inclusion
- Patients who had a medical diagnosis of COVID-19, clinically stable, able to respond to simple commands, able to walk for six minutes and who sign study consent form will be enrolled. Those who present associated neurological diseases, pregnant, users of psychoactive drugs, patients who have metallic implants, electronic devices, pacemakers, or epileptic patients will be excluded.
Exclusion
Key Trial Info
Start Date :
September 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 14 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05289115
Start Date
September 14 2021
End Date
July 14 2022
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Paraíba,Department of Psychology
João Pessoa, Paraíba, Brazil, 58051-900